Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Citigroup Upgrades Rigel Pharmaceuticals to Buy

Citigroup Upgrades Rigel Pharmaceuticals to Buy

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

byBenzinga Newsdesk

December 2, 2022

1 minute read

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

EV Startup Arrival Gets Hope For Survival From US IRA Subsidies: Report

By Lekha Gupta

May 25, 8:30 AM

Arrival (NASDAQ: ARVL) reportedly expects its recently disclosed merger deal and significant subsidies from the US Inflation Reduction Act (IRA) to drive its business growth.

ARVL

Analyst Ratings

BMO Capital Maintains Market Perform Rating for Atlantica Sustainable: Here’s What You Need To Know

By Benzinga Insights

September 22, 1:00 PM

BMO Capital has decided to maintain its Market Perform rating of Atlantica Sustainable (NASDAQ:AY) and lower its price…

Global
News

ECB To Launch New Program Of Bond Purchases Aimed At Countering Fragmentation

By Benzinga Newsdesk

July 21, 8:21 AM

- Dow Jones

VGK

Morgan Stanley Maintains Equal-Weight on ONE Gas, Raises Price Target to $89

By Benzinga Newsdesk

August 23, 8:28 AM

Morgan Stanley analyst Stephen Byrd maintains ONE Gas (NYSE:OGS) with a Equal-Weight and raises the price target from $82 to $89.

OGS

Citigroup Upgrades Rigel Pharmaceuticals to Buy

Related Posts

EV Startup Arrival Gets Hope For Survival From US IRA Subsidies: Report

BMO Capital Maintains Market Perform Rating for Atlantica Sustainable: Here’s What You Need To Know

ECB To Launch New Program Of Bond Purchases Aimed At Countering Fragmentation

Morgan Stanley Maintains Equal-Weight on ONE Gas, Raises Price Target to $89